Skip to content
DraconiticResearch
Search Sources API
182,469 studies31 sourcesUpdated 39 min ago
PreprintCC BYbioRxiv

Engineering circular RNA expression systems to minimize contaminating linear RNA byproducts

  1. 1Baylor College of Medicine

Abstract

Circular RNAs (circRNAs) are generated by backsplicing of eukaryotic protein-coding transcripts and can regulate microRNAs and RNA binding proteins, or serve as translation templates. Their covalently closed structure confers resistance to exonuclease-mediated degradation, extending their half-life and supporting their development as RNA therapeutics. However, existing overexpression methods often yield substantial contaminating linear RNAs, limiting their utility. Here, we systematically benchmarked plasmid-based circRNA overexpression strategies in human cells, comparing spliceosome- and ribozyme-based mechanisms across constructs incorporating widely used flanking sequences. The ribozyme-based Tornado system produced the highest circRNA yield but introduced extraneous "molecular scars" into the mature product. By contrast, spliceosome-mediated circularization using introns from the Drosophila Laccase2 gene, which contain imperfect complementary repeats, produced scarless circRNA with substantially lower linear RNA contamination. Linear RNA was further reduced by engineering the primary transcript to terminate in a non-polyadenylated end, increasing its susceptibility to exonucleases. Building on this optimized system, we developed a dual-output platform co-expressing a linear fluorescent reporter alongside a circRNA from a single promoter (CIRCUS, circRNA and upstream linear system), enabling efficient screening of circRNA-driven cellular phenotypes, including site-specific A-to-I editing of target mRNAs. Together, this toolkit provides high-purity circRNA production suitable for mechanistic studies and circRNA-based therapeutic development.

Related

  1. Assessing the impact of parental linear gene normalization on the performance of statistical models for circular RNA differential expression analysis
    Briefings in bioinformaticsPeer-reviewedCC BY-NCFull textMolecular biology & gene regulationEurope PMC
  2. Systematic engineering of synthetic minimal promoters for tunable transgene expression in mammalian cells
    Masha Zaitsev-Chaikovsky, Shira Shalev, Tali Lanton +2
    Nucleic Acids ResearchPeer-reviewedLicence not statedFull textMolecular biology & gene regulationCrossref
  3. Metal cofactor-level chassis engineering enables aerobic expression of tungsten formate dehydrogenases in Escherichia coli
    Uyen Thu Phan, Jun-Min Lee, Toan Minh Vo +2
    Nature CommunicationsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  4. Beyond marker expression: An ESC-informed framework for engineering and validating chicken induced pluripotent stem cells
    Usama Abdullah, Umar Sajid Kayani, M Khuzema Niaz +4
    Poultry SciencePeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationPMC
  5. A transient expression platform for rapid metabolic engineering of artemisinin biosynthesis in Artemisia annua
    Fabio Pietrolucci, Vittoria Valesi, Elena Sgaravatti +3
    Frontiers in Plant SciencePeer-reviewedCC BY 4.0Full textMolecular biology & gene regulationCrossref
BibTeX
@misc{fields2026engineering,
  title = {{Engineering circular RNA expression systems to minimize contaminating linear RNA byproducts}},
  author = {C. J. Fields and R. Fujiwara and B. W. Wright and B. W. Stringer and S. J. Conn and J. E. Wilusz},
  howpublished = {bioRxiv},
  year = {2026},
  month = sep,
  doi = {10.64898/2026.09.07.749908},
  url = {https://www.biorxiv.org/content/10.64898/2026.09.07.749908v1},
  note = {CC BY},
}
RIS
TY  - UNPB
TI  - Engineering circular RNA expression systems to minimize contaminating linear RNA byproducts
AU  - C. J. Fields
AU  - R. Fujiwara
AU  - B. W. Wright
AU  - B. W. Stringer
AU  - S. J. Conn
AU  - J. E. Wilusz
PY  - 2026
DA  - 2026/09/07
PB  - bioRxiv
DO  - 10.64898/2026.09.07.749908
UR  - https://www.biorxiv.org/content/10.64898/2026.09.07.749908v1
AB  - Circular RNAs (circRNAs) are generated by backsplicing of eukaryotic protein-coding transcripts and can regulate microRNAs and RNA binding proteins, or serve as translation templates. Their covalently closed structure confers resistance to exonuclease-mediated degradation, extending their half-life and supporting their development as RNA therapeutics. However, existing overexpression methods often yield substantial contaminating linear RNAs, limiting their utility. Here, we systematically benchmarked plasmid-based circRNA overexpression strategies in human cells, comparing spliceosome- and ribozyme-based mechanisms across constructs incorporating widely used flanking sequences. The ribozyme-based Tornado system produced the highest circRNA yield but introduced extraneous "molecular scars" into the mature product. By contrast, spliceosome-mediated circularization using introns from the Drosophila Laccase2 gene, which contain imperfect complementary repeats, produced scarless circRNA with substantially lower linear RNA contamination. Linear RNA was further reduced by engineering the primary transcript to terminate in a non-polyadenylated end, increasing its susceptibility to exonucleases. Building on this optimized system, we developed a dual-output platform co-expressing a linear fluorescent reporter alongside a circRNA from a single promoter (CIRCUS, circRNA and upstream linear system), enabling efficient screening of circRNA-driven cellular phenotypes, including site-specific A-to-I editing of target mRNAs. Together, this toolkit provides high-purity circRNA production suitable for mechanistic studies and circRNA-based therapeutic development.
ER  -